Albania medical device registration timeline
Source-linked clocksAlbanian Drugs and Medical Devices Agency (ABPM) review clocks and end-to-end planning ranges, using the 3-class (I, II, III) — Law No. 89/2018 classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class I(Registration with ABPM) Class I registration reviewed within 5 working days of a complete application (Law No. 89/2018 on medical devices) | 5 working days | 1-3 months | — | Verified |
| Class II(Registration with ABPM) Class II registration reviewed within 30 working days of a complete application (Law No. 89/2018) | 30 working days | 2-4 months | — | Verified |
| Class III(Registration with ABPM) Class III registration reviewed within 30 working days of a complete application (Law No. 89/2018) | 30 working days | 3-5 months | — | Verified |
Albania Medical Device Registration Process
Step-by-step ABPM registration process. Total estimated timeline: 1-3 months.
Step 1: Pre-Submission Preparation
1-3 monthsGather technical documentation, quality management system (QMS) records, and clinical data required by ABPM. Appoint a Albanian Authorized Representative.
Step 2: Application Submission
1-2 weeksSubmit complete registration dossier to ABPM including device description, risk analysis, and testing reports.
Step 3: Administrative Review
2-4 weeksABPM reviews application for completeness. May request additional documents or clarifications.
Step 4: Technical Evaluation
5 working daysIn-depth technical assessment of device safety and performance. ABPM may issue questions.
Step 5: Registration Approval
1-2 weeksUpon successful review, ABPM issues Albania market authorization certificate.
- Local Authorized Representative required for foreign manufacturers
- Deficiencies must be remedied within 30 days; applications lapse otherwise
- Amendment or cancellation of a registration decided within 30 working days
- Manufacturing/importation licence (VKM No. 227/2022): completeness 25 days, review 5 days, decision 30 days
- Clinical investigation authorisation within 60 days, with tacit approval if no decision issues